Biotechnology
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
11-50
employees, estimated range
Grants
$275k
1 grant · CORDIS
Backers
1
Y Combinator
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Grant | Aug 2023 | $275k | — | CORDIS |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Alia Therapeutics is a startup which is developing next-generation gene editing medicines to cure genetic diseases.

HarborSite pioneers programmable gene insertion technology using engineered recombinase enzymes to cure genetic diseases and unlock gene…

Cell and Gene Therapy. Cure Genetics Committed to the development of gene and cell therapy for oncology and genetic diseases Cure Genetics…

ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.

We're on a mission to fulfill the promise of genetic medicine for all patients. At Addition, we are advancing a pipeline of therapeutics to…

ARCUS Genome Editing. At Precision BioSciences, we are using our novel ARCUS genome-editing technology to develop a new class of medicines…
Overview
Uncover Cures for Genetic Diseases in Children with Rosebud Biosciences.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Francisco
United States
HQ
10-50 est. staff
Financials
Total raised
$275k
Latest round
Grant
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Grant | 2023 | $275k | Details |

Y Combinator 




